Rio Biopharmaceuticals

Rio Biopharmaceuticals is the U.S. subsidiary of EMS S/A, Brazil's largest pharmaceutical company. EMS S/A currently sells more than 500 generic and innovative products in Brazil and internationally. After receiving approval from the U.S. Food and Drug Administration, Rio Biopharmaceuticals will introduce selected products from this extensive portfolio to the U.S. market.